These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 37662612)

  • 21. SIRT1 activation and its circadian clock control: a promising approach against (frailty in) neurodegenerative disorders.
    Ribeiro RFN; Pereira D; de Almeida LP; Silva MMC; Cavadas C
    Aging Clin Exp Res; 2022 Dec; 34(12):2963-2976. PubMed ID: 36306110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases.
    Jiao F; Gong Z
    Oxid Med Cell Longev; 2020; 2020():6782872. PubMed ID: 33014276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Importance of NAMPT-mediated NAD-biosynthesis and NAD-dependent deacetylase SIRT1 in the crosstalk between circadian rhythm and metabolism].
    Yoshino J
    Nihon Rinsho; 2013 Dec; 71(12):2187-93. PubMed ID: 24437277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circadian transcription factor NPAS2 and the NAD
    Becker-Krail DD; Parekh PK; Ketchesin KD; Yamaguchi S; Yoshino J; Hildebrand MA; Dunham B; Ganapathiraju MK; Logan RW; McClung CA
    Eur J Neurosci; 2022 Feb; 55(3):675-693. PubMed ID: 35001440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the sirtuin silent information regulator 1 pathway inhibits pathological myocardial remodeling.
    Wang Y; Zhao R; Wu C; Liang X; He L; Wang L; Wang X
    Front Pharmacol; 2023; 14():1111320. PubMed ID: 36843938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence.
    Albani D; Polito L; Forloni G
    J Alzheimers Dis; 2010; 19(1):11-26. PubMed ID: 20061622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuroprotective role of silent information regulator 1 in Alzheimer's disease].
    Yang XR; Wang R; Qin HP; Zhao X; Liu NH; Zhang C
    Sheng Li Xue Bao; 2011 Aug; 63(4):396-400. PubMed ID: 21861060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deciphering therapeutic options for neurodegenerative diseases: insights from SIRT1.
    Wang R; Wu Y; Liu R; Liu M; Li Q; Ba Y; Huang H
    J Mol Med (Berl); 2022 Apr; 100(4):537-553. PubMed ID: 35275221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Sirt1 during the ageing process: relevance to protection of synapses in the brain.
    Godoy JA; Zolezzi JM; Braidy N; Inestrosa NC
    Mol Neurobiol; 2014 Dec; 50(3):744-56. PubMed ID: 24496572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of Sirt1: at the crossroad between promotion of longevity and protection against Alzheimer's disease neuropathology.
    Wang J; Fivecoat H; Ho L; Pan Y; Ling E; Pasinetti GM
    Biochim Biophys Acta; 2010 Aug; 1804(8):1690-4. PubMed ID: 19945548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism.
    Cui Z; Zhao X; Amevor FK; Du X; Wang Y; Li D; Shu G; Tian Y; Zhao X
    Front Immunol; 2022; 13():943321. PubMed ID: 35935939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A small molecule ApoE4-targeted therapeutic candidate that normalizes sirtuin 1 levels and improves cognition in an Alzheimer's disease mouse model.
    Campagna J; Spilman P; Jagodzinska B; Bai D; Hatami A; Zhu C; Bilousova T; Jun M; Elias CJ; Pham J; Cole G; LaDu MJ; Jung ME; Bredesen DE; John V
    Sci Rep; 2018 Dec; 8(1):17574. PubMed ID: 30514854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Sirtuin 1 (SIRT1) in Neurodegeneration.
    Razick DI; Akhtar M; Wen J; Alam M; Dean N; Karabala M; Ansari U; Ansari Z; Tabaie E; Siddiqui S
    Cureus; 2023 Jun; 15(6):e40463. PubMed ID: 37456463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RTN4B-mediated suppression of Sirtuin 2 activity ameliorates β-amyloid pathology and cognitive impairment in Alzheimer's disease mouse model.
    Wang Y; Yang JQ; Hong TT; Sun YH; Huang HL; Chen F; Chen XJ; Chen HY; Dong SS; Cui LL; Yang TL
    Aging Cell; 2020 Aug; 19(8):e13194. PubMed ID: 32700357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking SIRT1 inhibits cell proliferation and promotes aging through the PI3K/AKT pathway.
    Li H; Wang R
    Life Sci; 2017 Dec; 190():84-90. PubMed ID: 28962864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular imaging of NAD
    Xu Y; Chen Z; Wey HY; Liang Y; Tanzi RE; Zhang C; Wang C
    Alzheimers Dement; 2021 Dec; 17(12):1988-1997. PubMed ID: 33860595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1.
    Testa G; Staurenghi E; Giannelli S; Gargiulo S; Guglielmotto M; Tabaton M; Tamagno E; Gamba P; Leonarduzzi G
    Redox Biol; 2018 Jul; 17():423-431. PubMed ID: 29883958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer's disease.
    Scuderi C; Stecca C; Bronzuoli MR; Rotili D; Valente S; Mai A; Steardo L
    Front Pharmacol; 2014; 5():89. PubMed ID: 24860504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex-divergent effects on the NAD+-dependent deacetylase sirtuin signaling across the olfactory-entorhinal-amygdaloid axis in Alzheimer's and Parkinson's diseases.
    Cartas-Cejudo P; Lachén-Montes M; Ferrer I; Fernández-Irigoyen J; Santamaría E
    Biol Sex Differ; 2023 Feb; 14(1):5. PubMed ID: 36755296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Procyanidins and Alzheimer's Disease.
    Zhao S; Zhang L; Yang C; Li Z; Rong S
    Mol Neurobiol; 2019 Aug; 56(8):5556-5567. PubMed ID: 30649713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.